𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Juvenile dermatomyositis: clinical characteristics and the relatively high risk of interstitial lung disease

✍ Scribed by Yoichi Morinishi; Tsutomu Oh-Ishi; Tomoyuki Kabuki; Kosuke Joh

Publisher
Springer
Year
2007
Tongue
English
Weight
225 KB
Volume
17
Category
Article
ISSN
1439-7595

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Leflunomide use and the risk of intersti
Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis
✍ Samy Suissa; Marie Hudson; Pierre Ernst πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 66 KB πŸ‘ 2 views

## Abstract ## Objective Spontaneous reports of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) treated with leflunomide, a disease‐modifying antirheumatic drug (DMARD), have been appearing recently. To assess this risk, we conducted a population‐based epidemiologic stud

Validation and clinical significance of
Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies
✍ Adam M. Huber; Brian M. Feldman; Robert M. Rennebohm; Jeanne E. Hicks; Carol B. πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 153 KB πŸ‘ 2 views

## Abstract ## Objective To examine the measurement characteristics of the Childhood Myositis Assessment Scale (CMAS) in children with juvenile idiopathic inflammatory myopathy (juvenile IIM), and to obtain preliminary data on the clinical significance of CMAS scores. ## Methods One hundred eigh